Concepedia

Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib

Katrin Wenn, Lena Tomala, Stefan Wilop, Lucia Vankann, C Hasenbank, Andreas Hochhaus, Francis J. Giles, Thoralf Lange, Marc Müller, Steffen Koschmieder,

Leukemia · 2015 · 23 citations · 8 references

DOI

Concepts

References

8

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

JE Sokal, Cox Eb, Michele Baccarani et al. · Blood · 1984 · 1K citations · Full text

, , +13

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

JE Sokal, Cox Eb, Michele Baccarani et al. · Blood · 1984 · 962 citations

, , +13

Telomere length in leukocyte subpopulations of patients with aplastic anemia

Tim H. Brümmendorf, Jaroslaw P. Maciejewski, Jennifer Sze Man Mak et al. · Blood · 2001 · 232 citations

, , +13

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

Tim H. Brümmendorf, Tessa L. Holyoake, Nathalie Rufer et al. · Blood · 2000 · 205 citations

, , +17

Direct Comparison of Flow-FISH and qPCR as Diagnostic Tests for Telomere Length Measurement in Humans

Fernanda Gutierrez‐Rodrigues, Bárbara A. Santana-Lemos, Priscila Santos Scheucher et al. · PLoS ONE · 2014 · 194 citations · Full text

, , +12